SCHEMBL7983508

SCHEMBL7983508

CC(C)(C)C1(CNCc2ccccc2)CCCCN1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 1/20 0.40
KMT2A Q03164 1/20 0.39
OPRL1 P41146 1/20 0.37
MC4R P32245 2/20 0.37
FKBP1A P62942 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18544428 0.91 KDM4E (0.40) DPP7KMT2AOPRL1SMN1; SMN2
SCHEMBL2545928 0.84 METAP2 (0.42) KMT2AMC4R
SCHEMBL2545929 0.84 METAP2 (0.42) KMT2AMC4R
SCHEMBL337364 0.78 LMNA (0.45) SMN1; SMN2
SCHEMBL336767 0.78 LMNA (0.45) SMN1; SMN2
SCHEMBL2486251 0.76
SCHEMBL2486246 0.76
SCHEMBL14718566 0.74 DPP4 (0.40) DPP7KMT2AOPRL1
SCHEMBL25249805 0.73 KMT2A (0.39) DPP7KMT2AMC4R
SCHEMBL10002339 0.73 CXCR4 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235731-B1 REDUCING BLOOD LIPIDS, SUGARS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 US disclosed
EP-0915888-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS Takeda Chemical Industries, Ltd. (JP) 1999-05-19 EP disclosed
WO-1997040051-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-30 WO disclosed